Roger L. Nation

International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

Brian T. Tsuji, Jason M. Pogue, Alexandre Prehn Zavascki et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2019 · 931 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Colistin Resistance in <i>Acinetobacter baumannii</i> Is Mediated by Complete Loss of Lipopolysaccharide Production

Jennifer H. Moffatt, Marina Harper, Paul F. Harrison et al. · Antimicrobial Agents and Chemotherapy · 2010 · 792 citations

Life Sciences, Infectious Diseases, Microbiology +17

Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

Samira M. Garonzik, Jian Li, Visanu Thamlikitkul et al. · Antimicrobial Agents and Chemotherapy · 2011 · 685 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Heteroresistance to Colistin in Multidrug-Resistant <i>Acinetobacter baumannii</i>

Jian Li, Craig R. Rayner, Roger L. Nation et al. · Antimicrobial Agents and Chemotherapy · 2006 · 542 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens

Ana Maria Sandri, Cornelia B. Landersdorfer, Jovan Jacob et al. · Clinical Infectious Diseases · 2013 · 428 citations

Pharmacy, Pharmacokinetics, Pharmacology +16